Travere Therapeutics TVTX
NASDAQ TVTX
$59.99 -1.58 (-2.57%)
At close: Sep 29, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Notes Payables (2011 - 2015)

Updated

Travere Therapeutics' Notes Payables came in at $41.13 million for Q2 2015.

Analysis

Travere Therapeutics (TVTX) Notes Payables (2011 - 2015) Analysis & Trends

At the end of FY2014, Travere Therapeutics' Notes Payables was $40.49 million.

  • Notes Payables carries a three-year compound annual growth rate of 17.4% (FY2011 to FY2014).
  • Going back by year, Notes Payables was $884,764 in FY2012 and $25 million in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Travere Therapeutics 5.80 Bn 5.40 Bn 167.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 41.13 Mn
Dec 31, 2014 40.49 Mn
Nov 30, 2011 25.00 Mn
Feb 28, 2011 25.00 Mn
API Access

Travere Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=TVTX&period=max&api_key=YOUR_API_KEY